Hive Stock Investors: More Profits As Ethereum Hits New All-Time Highs

Hive Blockchain (TSXV:HIVE) could report strong earnings growth, thanks largely to an Ethereum rally that has pulled the crypto miner’s stock recently.

| More on:

Investors in Hive Blockchain (TSXV:HIVE) stock could enjoy a good week of capital gains if Ethereum maintains its current price growth momentum. Ethereum, the world’s second-largest cryptocurrency by market capitalization, recorded an all-time high price of US$2,151.25 during early hours on Tuesday. The coin has so far rallied by 189% so far this year and here’s why this has been a celebrated development for Hive stock.

Hive stock could benefit from an Ethereum rally

Hive is currently the only publicly traded cryptocurrency mining stock offering investors significant exposure to Ethereum mining economics. The rise in the crypto coin’s price will boost company’s revenue and profitability in the next quarterly earnings.

As the altcoin’s price surges, the total revenue for miners increases too. Add to that the effect of an ongoing increase in decentralized finance (DeFi) applications and related total transactions on Ethereum’s blockchain on transaction fees, and we have a beautiful setup for Ether miners.

Ethereum miner monthly revenue keeps increasing to Hive's benefit. (data as of April 6, 2021)
Rising transaction fees benefit Hive stock as Ethereum mining revenue surges. (Source: The Block)

Total revenue for Ethereum miners during the first five days of April has already exceeded that for the entire month of October 2020. The company is partaking in this ecosystem’s economic gains. As transaction fees explode in 2021, and I can’t wait to see how HIVE’s earnings will react to this nice industry setup.

Bitcoin price surge to compliment Ethreum’s impact on earnings

Hive stock investors may expect a significant earnings boost to the company’s quarterly results for March 2021 from both Bitcoin and Ether.

The company mined about 21,500 Ethereum coins and produced 165 Bitcoins during the final quarter of last year. It reported US$17.2 million in earnings before tax for the quarter ending December 31, 2020. Management estimated that a “mere” 25% change in Ethereum’s market price during that quarter could increase earnings by US$2.4 million. A similar increase in Bitcoin’s market price could have increased earnings by US$1.3 million.

The recent quarter saw Ethereum price rising by 160% and Bitcoin rising by 103% by March 31, 2021. Assuming all other variables do not change since December, observed moves in the respective cryptocurrencies could result in a 120% increase in quarterly profit for Hive to nearly US$38 million.

Things have changed of course, but the company could report significant revenue and profit increases in the next financial statements.

Time to buy?

The volatility in cryptocurrency prices naturally reflects on crypto mining tickers, and Hive’s stock is no different. If you can stomach the wild swings experienced historically, then the opportunity to buy and hold is still available.

Hive Blockchain’s exposure to a more DeFi friendly blockchain platform gives it access to a revolutionary Ethereum ecosystem that’s challenging traditional financial intermediation. The company could enjoy recurring business from transaction fee-generating operations, even if mining economics take a sudden knock.

Management intends to diversify the firm’s operating exposures. It is investigating artificial intelligence (AI), and other highly-efficient computing applications for its data centers in Sweden and Iceland. Private blockchain computing could be offered too.

Investors could therefore see dampened volatility in the long term as diversification benefits smoothen earnings. The recently announced transaction with blockchain services firm DeFi Technologies is another interesting growth-focused partnership that could deliver the goods for shareholders.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Paradza has no position in any of the stocks mentioned.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »